Beta-blockers (BBs) are a large and important family of therapeutic agents with primary use is in cardiovascular medicine. This title provides an update of beta-blockers use in cardiovascular area. It uncovers the clinical inaccuracies of how the UK NICE Committee have 'got it wrong' in their recent pronouncements on BBs and hypertension.
